Click on the slide!

Stem Cells Translational Medicine

Bridging basic stem cell research and its ultimate expression through clinical trials.

Dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology.

More...
Click on the slide!

The Oncologist

The International Peer-Reviewed Journal for the Practicing Oncologist/Hematologist

Oncology and hematology professionals are continuously charged with staying on the cutting–edge of new medical treatments and technologies to foster…

More...
Click on the slide!

Stem Cells

The International Journal of Cell Differentiation and Proliferation

A premier journal in its field, Stem Cells, the international journal of cell differentiation and proliferation, publishes peer-accepted original articles…

More...
Click on the slide!

Stem Cells Portal

Uniting Researchers & Resources: The Stem Cells Journal Online Community

Collaborate, discuss, and network.

More...
Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks

Studies test effectiveness and safety of stem cell treatment for urinary incontinence

Medication and minimally invasive surgery to implant a sling can provide relief for millions of people who suffer from stress urinary incontinence (SUI), but not everyone responds to these therapeutic methods. A new study in the current STEM CELLS Translational Medicine tests the safety and effectiveness of stem cells as an alternative SUI treatment.

Read more...

 

New stem cell production method could clear way for anticancer gene therapy

A new study released today in STEM CELLS Translational Medicine suggests a new way to produce endothelial progenitor cells in quantities large enough to be feasible for use in developing new cancer treatments.

Read more...

   

Cholesterol drug and radiation combo could halt recurrence of aggressive breast cancer

Patients with a particularly stubborn type of breast cancer could potentially benefit by supplementing radiation treatments with a generic, low-cost medication commonly prescribed to treat high cholesterol, according to a new study released today in Stem Cells Translational Medicine.

Read more...

   

Stem cells could be the answer for treating fecal incontinence after injury or disease

A new study released today in STEM CELLS Translational Medicine demonstrates the regenerative effects of mesenchymal stem cells (MSC) on the anal sphincter. The work could have implications for the 11 percent of the population suffering fecal incontinence due to an injury or disease.

Read more...

   

Lower starting doses of sorafenib feasible for advanced thyroid cancer

A new study published in The Oncologistjournal shows that a subset of patients with advanced differentiated thyroid cancer (DTC) and multiple comorbidities in which full-dose sorafenib is considered unsafe can initiate treatment with sorafenib at lower starting doses without adversely affecting efficacy or tolerability compared with full-dose sorafenib. A team of researchers led by Ramona Dadu, MD, at the MD Anderson Cancer Center in Houston, TX, performed a retrospective analysis to evaluate the relationship between sorafenib starting doses and first-line treatment tolerability and efficacy.

Read more...

   

Page 1 of 2

amp.goldstandardtran

RocketTheme Joomla Templates
Cipro Doxycycline
http://journals.alphamedpress.com/combivent-generic.html http://journals.alphamedpress.com/finpecia-online.html http://journals.alphamedpress.com/revatio-online.html http://journals.alphamedpress.com/rimonabant-fda.html http://journals.alphamedpress.com/salbutamol-tablets.html